{"filing":{"accession_number":"0001193125-26-349180","cik":"0001469443","ticker":"RKDA","company_name":"Arcadia Biosciences, Inc.","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"rkda-20260813.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1469443/000119312526349180/rkda-20260813.htm"},"events":[{"id":27592,"run_id":25158,"accession_number":"0001193125-26-349180","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a clear earnings release disclosing Arcadia Biosciences' financial results for Q2 and H1 2026. The press release (Exhibit 99.1) announces quarterly revenues, operating expenses, net loss per share, and cash position, with supporting financial statements (balance sheet, income statement, cash flow statement) in Exhibit 99.2. The Item 2.02 disclosure and attached exhibits are the standard format for quarterly earnings announcements.","company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":29182,"accession_number":"0001193125-26-349180","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Arcadia Biosciences' financial results for Q2 and H1 2026. The press release (Exhibit 99.1) announces quarterly revenues, operating expenses, net loss per share, and cash position, with supporting financial statements (balance sheet, income statement, cash flow statement) in Exhibit 99.2. The Item 2.02 disclosure and attached exhibits are the standard format for quarterly earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:02:15.057586+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29182,"accession_number":"0001193125-26-349180","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Arcadia Biosciences' financial results for Q2 and H1 2026. The press release (Exhibit 99.1) announces quarterly revenues, operating expenses, net loss per share, and cash position, with supporting financial statements (balance sheet, income statement, cash flow statement) in Exhibit 99.2. The Item 2.02 disclosure and attached exhibits are the standard format for quarterly earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:02:15.057586+00:00","company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","filing_date":"2026-08-13"}]}